Amarin Corporation plc (AMRN) is a biopharmaceutical company focused on improving cardiovascular health with its flagship product, Vascepa. Vascepa is a prescription omega-3 treatment designed to help reduce cardiovascular risk in patients with high triglycerides. The company’s growth is driven by expanding global approvals, increasing physician adoption, and the rising need for heart health treatments as cardiovascular disease remains a leading concern worldwide.
On the chart, a confirmation bar with increasing volume signals strong buying momentum. The price has entered the momentum zone by breaking above the .236 Fibonacci level. Traders can set a trailing stop just below this level using the Fibonacci snap tool to protect profits while allowing room for further upside.
On the chart, a confirmation bar with increasing volume signals strong buying momentum. The price has entered the momentum zone by breaking above the .236 Fibonacci level. Traders can set a trailing stop just below this level using the Fibonacci snap tool to protect profits while allowing room for further upside.
Read on substack
link.traderspro.com/k2r16ljr
Indicator Suite Setup
link.traderspro.com/gvm0e9df
Learn this trading method
link.traderspro.com/f39nzb0t
Daily email newsletter
link.traderspro.com/kuPneCQK
link.traderspro.com/k2r16ljr
Indicator Suite Setup
link.traderspro.com/gvm0e9df
Learn this trading method
link.traderspro.com/f39nzb0t
Daily email newsletter
link.traderspro.com/kuPneCQK
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Read on substack
link.traderspro.com/k2r16ljr
Indicator Suite Setup
link.traderspro.com/gvm0e9df
Learn this trading method
link.traderspro.com/f39nzb0t
Daily email newsletter
link.traderspro.com/kuPneCQK
link.traderspro.com/k2r16ljr
Indicator Suite Setup
link.traderspro.com/gvm0e9df
Learn this trading method
link.traderspro.com/f39nzb0t
Daily email newsletter
link.traderspro.com/kuPneCQK
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.